GlobeNewswire

Hoylu AB: HOYLU ANNOUNCES IMMEDIATE RELEASE OF HOYLU SUITE 3.5

Dela

Malmo, Sweden, March 1, 2018 - Hoylu, a leader in enterprise collaboration products, announced the immediate release of Hoylu Suite 3.5, a major software update available to all current subscribers. This release continues to focus on improving the user experience and delivering many valuable new features including expanded support for Anytime Collaboration, workspace customization, personalization and additional device and language support. The update reinforces why Hoylu's software is the most versatile collaboration system in the market today, and why the Hoylu Suite has won multiple awards for Best-In-Class Innovation for the Enterprise Workplace.

"Our goal is to provide intuitive digital workspaces that are essential to any global enterprise. We offer teams the flexibility to work on the same page across industries and disciplines no matter where they are in the world. With a focus on global sustainability and connecting teams together, Hoylu aims at being a vital part of any business that wants to work more efficiently and with ease," said Stein Revelsby, CEO of Hoylu.

Key release features include:

Dynamic Weblink Support

Web links can easily be added to a workspace for easy reference, simply drag in or add web references for anything. This allows workspaces to be connected to third party applications like JIRA or Visual Studio, as well as image and video libraries to provide a single source for storing and reviewing material in a single location. The infinite canvas allows all information to stay together further reducing hassles for keeping key business information together.

Workspace Customization

After significant demand, Hoylu Suite now has additional support for templates, libraries and different types of workspaces expertly designed specifically for key construction, education and project workflows, as well as sports activities. Additional shapes and icon libraries were added to assist with workflow scenarios like creating engineering diagrams, work plan review and process workflows. Each of these items allow for workspaces to be customized for key needs in each industry.

Keyboard Text Entry

Keyboards can now be used to type directly into a workspace for those situations when more formal presentation and clarity is needed. The combination of handwriting capabilities and now keyboard entry provides further accessibility for any user of the product from Agile and Lean planning activities, brainstorming or sharing content across continents.

Personalized Localization

Hoylu also has announced full native localization for its markets around the world, with the

ability to select languages by individual user account. This capability allows teams in different regions to work natively and communicate globally.

Browser Support

Hoylu's software is now available through any standard browser on both Windows, Android and Apple devices, making communication through a Hoylu workspace possible on every device from the large Huddlewall sized projection screens, interactive touch displays, personal desktop, laptop, tablets and mobile phones.

Performance and Security Enhancements

Hoylu Suite has made several performance improvements for quicker, more responsive shared sessions. Also, additional password security options are now available for stronger workspace protection that can be extended to individuals and/or groups. And for added convenience, workspaces can now be named for easier sharing and group collaboration.

 

For more information, please contact:

Stein Revelsby, CEO at Hoylu +1 213 440 2499 Email: sr@hoylu.com

Karl Wiersholm, CFO at Hoylu +1 425 829 2316 Email: kw@hoylu.com

 

About Hoylu

Hoylu delivers solutions to allow enterprises to plan, assemble and evolve with a focus on enriching the user experience. The Hoylu Suite delivers a comprehensive set of personalized digital workspaces to enable teams across locations, on any device, to work smarter and with more fun across major industries including Engineering, Pharmaceutical, Construction, Manufacturing, Travel, Hospitality, Graphic Design and many more. The Hoylu Suite allows users to create and share workspaces for free form sketching, drawing, mark-ups and organization of documents, pictures, video-links and other types of content on an infinite canvas. The Hoylu Suite is built to be easy to use and engaging with the objective to enhance productivity and simplify work processes for teams and people across multiple disciplines, while working in the same room or in multiple locations. For more information visit: www.hoylu.com or www.introduce.se/foretag/hoylu

 

Ticker symbol: Hoylu

Marketplace: Nasdaq First North Stockholm

Certified Adviser: Mangold Fondkommission AB +46 (0) 8 50 301 550

 

Publication

The information was submitted for publication,  through the agency of the contact person set out above, at (8:50) CEST on March 1, 2018.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hoylu AB via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum